Beneficial Effects of Anti-Apolipoprotein A-2 on an Animal Model for Coronary Arteritis in Kawasaki Disease-Reference-Cited by-同舟云学术

Beneficial Effects of Anti-Apolipoprotein A-2 on an Animal Model for Coronary Arteritis in Kawasaki Disease

Published:2022-10-12 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Ito Fuyu¹^ORCID,Oharaseki Toshiaki²,Tsukui Daisuke³,Kimura Yoshitaka³,Yanagida Tamiko³,Kishi Fukuko⁴,Yamakawa Yoshio⁴,Kameoka Yosuke⁴,Suzuki Shoichi¹,Uno Kazuko⁵,Suzuki Osamu⁶,Miura Noriko N⁷,Ohno Naohito⁸,Takahashi Kei²,Kono Hajime³,Suzuki Kazuo¹

Affiliation:

1. Teikyo University: Teikyo Daigaku

2. Toho University Medical Center Ohashi Hospital: Toho Daigaku Iryo Center Ohashi Byoin

3. Teikyo University School of Medicine

4. A-CLIP Institute

5. Louis Pasteur Center for Medical Research

6. National Institutes of Biomedical Innovation, Health and Neutrition

7. Tokyo University of Pharmacy and Life Sciences: Tokyo Yakka Daigaku

8. Tokyo University of Pharmacy and Life Science: Tokyo Yakka Daigaku

Abstract

Abstract Background Kawasaki disease (KD) is usually treated with high-dose intravenous immunoglobulin (IVIg) as severe infectious and other diseases. Due to issues that are associated with immunoglobulin preparation, such as the risk of possible contamination by infectious agents and limited blood banking resources, recombinant immunoglobulins are required.

Publisher

Research Square Platform LLC

Reference35 articles.

1. Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with Covid-19 in pediatric emergency departments in Italy;Parri N;N Engl J Med,2020

2. COVID-19 and Kawasaki disease: novel virus and novel case;Jones VG;Hosp Pediatr,2020

3. Acute febrile muco-cutaneous lymph node syndrome in young children with unique digital desquamation (clinical observation of 50 cases observed at our institution);Kawasaki T;Allergy,1967

4. Experimental Candida-induced arteritis in mice. Relation to arteritis in the mucocutaneous lymph node syndrome;Murata H;Microbiol Immunol,1979

5. Contribution of myeloperoxidase to coronary artery vasculitis associated with MPO-ANCA production;Ishida-Okawara A;Inflammation,2001